Kara Delaney
About Kara Delaney
Kara Delaney is the Associate Director of Immunology Customer & Market Insights at Bristol Myers Squibb, with over a decade of experience in market research and customer insights.
Title
Kara Delaney is currently the Associate Director, Immunology Customer & Market Insights at Bristol Myers Squibb. She has been in this role since June 2021.
Career at Bristol Myers Squibb
Kara Delaney joined Bristol Myers Squibb in June 2021. In her role as Associate Director, Immunology Customer & Market Insights, she focuses on providing deep insights into customer behaviors and market trends within the immunology sector. Her extensive background in market research supports her ability to drive strategic initiatives and informed decision-making at the company.
Career at Adelphi Research Global
Kara Delaney worked at Adelphi Research Global in various roles for nearly a decade, from 2011 to 2021. She started as a Project Associate and progressed to roles including Senior Project Director, Director, and Team Lead. Her responsibilities included leading research projects, managing teams, and providing strategic insights into market trends in the pharmaceutical industry. She operated primarily in the Greater Philadelphia Area during her tenure at Adelphi.
Educational Background
Kara Delaney holds a Master of Business Administration (MBA) from DeSales University, which she obtained between 2017 and 2021. She also earned a Bachelor's degree in Business with a focus on Marketing from Penn State University, graduating in 2011. Her educational background has provided her with a strong foundation in business principles and marketing strategies.
Professional Experience
Kara Delaney has over a decade of experience in market research and customer insights. She started her career at NMS Labs as a Marketing Intern, where she worked from 2008 to 2009 and again from 2010 to 2011. Her extensive experience in both marketing and market research has equipped her with the skills to excel in her current role at Bristol Myers Squibb, focusing on immunology market insights.